Aromatic Amino Acid [EPC]

Aromatic Amino Acid [EPC] was reported 60361 times

Drugs of the Aromatic Amino Acid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DOPAMINE DYSREGULATION SYNDROME 171 0.3834
1 DEEP BRAIN STIMULATION 230 0.3808
2 FREEZING PHENOMENON 1127 0.3041
3 SALIVA DISCOLOURATION 101 0.3024
4 STOMA SITE IRRITATION 162 0.2978
5 PARKINSONISM HYPERPYREXIA SYNDROME 46 0.2570
6 ON AND OFF PHENOMENON 1426 0.2566
7 STOMA SITE DISCHARGE 700 0.2555
8 STOMA SITE ERYTHEMA 472 0.2524
9 STOMA SITE INFECTION 316 0.2427
10 STOMA SITE ODOUR 53 0.2366
11 STOMA SITE HYPERGRANULATION 143 0.2266
12 STOMA SITE PAIN 330 0.2245
13 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 105 0.2104
14 STOMA SITE REACTION 139 0.2029
15 CATHETER SITE NODULE 38 0.1990
16 STOMA SITE EXTRAVASATION 75 0.1943
17 STOMA SITE DISCOMFORT 44 0.1938
18 JEALOUS DELUSION 53 0.1873
19 DEVICE COLOUR ISSUE 73 0.1807
20 CATHETER SITE INDURATION 33 0.1710
21 PATHOLOGICAL GAMBLING 279 0.1680
22 STOMA SITE OEDEMA 34 0.1553
23 REDUCED FACIAL EXPRESSION 136 0.1340
24 PARKINSON'S DISEASE 338 0.1329
25 STOMA SITE HAEMORRHAGE 202 0.1311
26 CAMPTOCORMIA 31 0.1292
27 MEDICAL DEVICE CHANGE 68 0.1276
28 VITAMIN B6 DEFICIENCY 31 0.1260
29 THERAPEUTIC PRODUCT EFFECT VARIABLE 472 0.1215
30 STOMA SITE INFLAMMATION 89 0.1191
31 DRUG EFFECT VARIABLE 134 0.1183
32 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 46 0.1144
33 PRODUCT RESIDUE PRESENT 601 0.1113
34 STOMA COMPLICATION 113 0.1112
35 DEVICE ALARM ISSUE 198 0.1090
36 MULTIPLE SYSTEM ATROPHY 38 0.1080
37 VASCULAR ENCEPHALOPATHY 30 0.1056
38 BRADYKINESIA 613 0.1037
39 HYPERSEXUALITY 189 0.1033
40 IMPULSE-CONTROL DISORDER 212 0.1029
41 LIVING IN RESIDENTIAL INSTITUTION 191 0.1018
42 FIBROMA 90 0.0979
43 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 97 0.0963
44 PARKINSONIAN GAIT 60 0.0962
45 DYSKINESIA 3737 0.0919
46 DEMENTIA WITH LEWY BODIES 96 0.0863
47 DEVICE PROGRAMMING ERROR 27 0.0852
48 ENTERAL NUTRITION 49 0.0845
49 DROPPED HEAD SYNDROME 33 0.0835
50 AKINESIA 171 0.0825
51 PATIENT ELOPEMENT 30 0.0820
52 HYPERKINESIA 169 0.0796
53 EUTHANASIA 25 0.0789
54 YAWNING 195 0.0730
55 REHABILITATION THERAPY 273 0.0704
56 DEVICE KINK 255 0.0699
57 MUSCLE RIGIDITY 821 0.0686
58 COMPULSIONS 45 0.0676
59 DEVICE CONNECTION ISSUE 139 0.0658
60 HALLUCINATION 4937 0.0654
61 NASAL DISCHARGE DISCOLOURATION 90 0.0652
62 DEVICE LOOSENING 56 0.0647
63 MUCOSAL DISCOLOURATION 41 0.0639
64 DELUSION 972 0.0625
65 EXPULSION OF MEDICATION 33 0.0624
66 COMPULSIVE SHOPPING 127 0.0617
67 SLEEP ATTACKS 29 0.0609
68 RESTING TREMOR 39 0.0604
69 DEVICE OCCLUSION 846 0.0601
70 PLEUROTHOTONUS 53 0.0586
71 PHYSIOTHERAPY 30 0.0581
72 HALLUCINATION, VISUAL 1224 0.0579
73 GAMBLING 67 0.0575
74 POSTURE ABNORMAL 185 0.0568
75 SUDDEN ONSET OF SLEEP 74 0.0533
76 MEDICAL DEVICE SITE PAIN 29 0.0515
77 INFUSION SITE CELLULITIS 27 0.0511
78 STEREOTYPY 46 0.0488
79 INFUSION SITE NODULE 46 0.0479
80 NONSPECIFIC REACTION 260 0.0473
81 SUSPICIOUSNESS 33 0.0469
82 SALIVA ALTERED 42 0.0467
83 LIBIDO INCREASED 94 0.0463
84 HALLUCINATION, TACTILE 30 0.0450
85 HALLUCINATIONS, MIXED 184 0.0437
86 FEAR OF FALLING 34 0.0417
87 DELUSIONAL DISORDER, UNSPECIFIED TYPE 31 0.0414
88 INTENTIONAL UNDERDOSE 283 0.0387
89 BLADDER CATHETERISATION 37 0.0382
90 SLEEP TALKING 63 0.0371
91 CATHETER SITE RELATED REACTION 27 0.0360
92 HOSPICE CARE 353 0.0357
93 THERAPEUTIC PRODUCT EFFECT DELAYED 155 0.0339
94 COGWHEEL RIGIDITY 35 0.0333
95 DYSTONIA 637 0.0328
96 PARKINSONISM 307 0.0315
97 DROOLING 216 0.0312
98 DEMENTIA 855 0.0306
99 DEVICE USE ISSUE 535 0.0306
100 PRESCRIBED OVERDOSE 589 0.0304
101 GASTROSTOMY 47 0.0303
102 OBSESSIVE-COMPULSIVE DISORDER 243 0.0303
103 BINGE EATING 32 0.0297
104 THERAPEUTIC RESPONSE SHORTENED 964 0.0290
105 FINE MOTOR SKILL DYSFUNCTION 82 0.0283
106 DRUG EFFECT DELAYED 127 0.0280
107 PRODUCT PACKAGING DIFFICULT TO OPEN 73 0.0279
108 BEZOAR 38 0.0275
109 HYPOKINESIA 395 0.0272
110 ORTHOSTATIC HYPOTENSION 473 0.0271
111 ILLUSION 44 0.0266
112 TENSION 159 0.0261
113 SPUTUM DISCOLOURED 245 0.0258
114 SLOW SPEECH 62 0.0255
115 GAMBLING DISORDER 68 0.0251
116 INFUSION SITE INDURATION 37 0.0249
117 INFUSION SITE MASS 27 0.0248
118 DYSGRAPHIA 162 0.0246
119 IMPULSIVE BEHAVIOUR 92 0.0245
120 DEVICE DISLOCATION 1055 0.0242
121 INFUSION SITE IRRITATION 31 0.0241
122 PERSECUTORY DELUSION 60 0.0240
123 TORTICOLLIS 51 0.0240
124 UTERINE PROLAPSE 26 0.0239
125 PARANOIA 411 0.0238
126 TREMOR 3881 0.0234
127 CHOKING 454 0.0232
128 CHOKING SENSATION 126 0.0228
129 CHOREA 39 0.0226
130 PRODUCT CLEANING INADEQUATE 60 0.0225
131 COMMUNICATION DISORDER 84 0.0219
132 NEUROLEPTIC MALIGNANT SYNDROME 255 0.0215
133 INFUSION SITE BRUISING 46 0.0213
134 SPEECH DISORDER 1096 0.0209
135 FLUID INTAKE REDUCED 101 0.0202
136 IMMOBILE 88 0.0201
137 ANTICHOLINERGIC SYNDROME 32 0.0201
138 DEVICE ISSUE 1781 0.0198
139 INFUSION SITE INFECTION 46 0.0198
140 WHEELCHAIR USER 88 0.0198
141 CATHETER SITE ERYTHEMA 42 0.0196
142 PNEUMONIA ASPIRATION 489 0.0196
143 SUBILEUS 40 0.0192
144 NOCTURIA 233 0.0192
145 FAECALOMA 104 0.0190
146 GAIT INABILITY 628 0.0188
147 PRESCRIBED UNDERDOSE 366 0.0183
148 HIP FRACTURE 589 0.0183
149 DYSCHEZIA 55 0.0180
150 APRAXIA 26 0.0175
151 TERMINAL INSOMNIA 31 0.0175
152 STARING 42 0.0174
153 MEDICAL DEVICE REMOVAL 30 0.0173
154 ABNORMAL DREAMS 479 0.0173
155 DRUG EFFECT LESS THAN EXPECTED 257 0.0173
156 ABNORMAL BEHAVIOUR 687 0.0173
157 MEDICAL DEVICE IMPLANTATION 27 0.0172
158 SALIVARY HYPERSECRETION 172 0.0172
159 BEHAVIOUR DISORDER 93 0.0172
160 MOVEMENT DISORDER 552 0.0172
161 BALANCE DISORDER 1475 0.0170
162 MEDICAL DEVICE DISCOMFORT 52 0.0170
163 GASTROINTESTINAL TUBE INSERTION 42 0.0168
164 AORTIC VALVE INCOMPETENCE 71 0.0167
165 CATHETER SITE PAIN 43 0.0166
166 FALL 5421 0.0163
167 CONFUSIONAL STATE 2620 0.0162
168 DYSSTASIA 464 0.0159
169 FOOD INTERACTION 28 0.0159
170 GAZE PALSY 27 0.0158
171 MOTOR DYSFUNCTION 161 0.0158
172 DEVICE POWER SOURCE ISSUE 46 0.0157
173 PSYCHOTIC DISORDER 464 0.0157
174 RESTLESS LEGS SYNDROME 284 0.0156
175 INFUSION SITE REACTION 46 0.0154
176 HYPERPHAGIA 61 0.0153
177 INFREQUENT BOWEL MOVEMENTS 38 0.0152
178 TERMINAL STATE 102 0.0152
179 CERVICAL VERTEBRAL FRACTURE 52 0.0151
180 CEREBRAL ATROPHY 60 0.0150
181 PROSTATOMEGALY 59 0.0150
182 DECUBITUS ULCER 122 0.0150
183 IMPAIRED SELF-CARE 31 0.0149
184 BRADYPHRENIA 97 0.0148
185 BLOOD SODIUM INCREASED 40 0.0148
186 HYPOPHAGIA 377 0.0147
187 AUTONOMIC NERVOUS SYSTEM IMBALANCE 43 0.0147
188 COGNITIVE DISORDER 685 0.0147
189 SKIN LACERATION 158 0.0145
190 CATATONIA 76 0.0145
191 VOLVULUS 34 0.0143
192 ASPIRATION 157 0.0143
193 MOBILITY DECREASED 1025 0.0143
194 HYPERSOMNIA 407 0.0142
195 DELIRIUM 485 0.0140
196 DEVICE PHYSICAL PROPERTY ISSUE 107 0.0140
197 CLAVICLE FRACTURE 52 0.0136
198 UNRESPONSIVE TO STIMULI 350 0.0135
199 INITIAL INSOMNIA 139 0.0135
200 HEAD INJURY 425 0.0134
201 SCREAMING 85 0.0133
202 AGGRESSION 663 0.0132
203 VITAMIN B12 DECREASED 38 0.0132
204 GAIT DISTURBANCE 2516 0.0131
205 INCOHERENT 85 0.0131
206 DIZZINESS POSTURAL 127 0.0131
207 HALLUCINATION, AUDITORY 207 0.0130
208 NIGHTMARE 444 0.0128
209 EMBEDDED DEVICE 127 0.0128
210 RESTLESSNESS 469 0.0128
211 UNINTENTIONAL MEDICAL DEVICE REMOVAL 148 0.0128
212 FAILURE TO THRIVE 66 0.0127
213 METABOLIC ENCEPHALOPATHY 38 0.0126
214 SLEEP TERROR 53 0.0126
215 LIVEDO RETICULARIS 26 0.0124
216 MIDDLE INSOMNIA 231 0.0124
217 SOMNOLENCE 2484 0.0123
218 MUSCULOSKELETAL STIFFNESS 1077 0.0123
219 MEDICAL DEVICE PAIN 26 0.0121
220 DISORIENTATION 481 0.0121
221 DYSPHAGIA 1152 0.0121
222 FACE INJURY 46 0.0121
223 MASTICATION DISORDER 37 0.0121
224 AGITATION 884 0.0120
225 INCONTINENCE 126 0.0119
226 BLOOD PRESSURE FLUCTUATION 286 0.0119
227 SPINAL STENOSIS 49 0.0119
228 PSYCHOMOTOR HYPERACTIVITY 197 0.0119
229 FAECES HARD 46 0.0118
230 RIB FRACTURE 243 0.0118
231 ACUTE PSYCHOSIS 29 0.0117
232 INFUSION SITE ERYTHEMA 96 0.0114
233 URINARY TRACT OBSTRUCTION 27 0.0114
234 LOGORRHOEA 40 0.0113
235 LISTLESS 37 0.0112
236 DYSPHEMIA 49 0.0112
237 PELVIC FRACTURE 87 0.0112
238 ADVERSE EVENT 1028 0.0111
239 POOR QUALITY SLEEP 240 0.0111
240 ABNORMAL FAECES 91 0.0111
241 WALKING AID USER 73 0.0111
242 EMERGENCY CARE 33 0.0109
243 HYPERVENTILATION 63 0.0109
244 FEMORAL NECK FRACTURE 55 0.0107
245 DECREASED INTEREST 63 0.0107
246 DEVICE PLACEMENT ISSUE 38 0.0106
247 NEGATIVE THOUGHTS 31 0.0106
248 URINARY TRACT INFECTION 1787 0.0105
249 BENIGN PROSTATIC HYPERPLASIA 54 0.0104
250 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 502 0.0104
251 APHASIA 314 0.0104
252 CATHETER SITE HAEMORRHAGE 26 0.0104
253 PRODUCT COMMUNICATION ISSUE 91 0.0103
254 MYOCLONUS 123 0.0103
255 SLUGGISHNESS 105 0.0103
256 DEVICE DIFFICULT TO USE 681 0.0103
257 PRODUCT USE COMPLAINT 162 0.0103
258 BEDRIDDEN 135 0.0103
259 BOWEL MOVEMENT IRREGULARITY 78 0.0102
260 DRUG EFFECT INCOMPLETE 369 0.0101
261 TRISMUS 52 0.0101
262 HYPOMANIA 37 0.0101
263 HYPERTONIC BLADDER 29 0.0100
264 PRE-EXISTING CONDITION IMPROVED 62 0.0099
265 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 702 0.0099
266 DYSARTHRIA 371 0.0098
267 THERAPY CESSATION 505 0.0098
268 ANAL INCONTINENCE 88 0.0098
269 COUGH 2719 0.0097
270 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 164 0.0096
271 BLOOD PRESSURE DECREASED 634 0.0095
272 MICTURITION URGENCY 108 0.0094
273 PRODUCT PHYSICAL ISSUE 189 0.0094
274 FRUSTRATION TOLERANCE DECREASED 74 0.0091
275 INFUSION SITE HAEMORRHAGE 30 0.0091
276 TRICUSPID VALVE INCOMPETENCE 72 0.0091
277 HIP SURGERY 49 0.0090
278 DRY THROAT 92 0.0090
279 HYPOPNOEA 31 0.0089
280 LUMBAR SPINAL STENOSIS 26 0.0089
281 SKIN ABRASION 42 0.0089
282 COMPLICATION ASSOCIATED WITH DEVICE 129 0.0089
283 ERYSIPELAS 44 0.0087
284 INFUSION SITE SWELLING 55 0.0087
285 PERSONALITY CHANGE 81 0.0087
286 THERAPEUTIC PRODUCT EFFECT DECREASED 390 0.0087
287 UNEVALUABLE EVENT 655 0.0086
288 FACIAL BONES FRACTURE 31 0.0086
289 GASTROINTESTINAL MOTILITY DISORDER 46 0.0086
290 DEVICE BREAKAGE 347 0.0085
291 FEEDING DISORDER 173 0.0085
292 GASTROINTESTINAL SOUNDS ABNORMAL 42 0.0085
293 MANIA 139 0.0084
294 ANXIETY DISORDER 28 0.0084
295 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 391 0.0084
296 BRUXISM 45 0.0083
297 HAND FRACTURE 59 0.0083
298 MALNUTRITION 93 0.0083
299 PANIC DISORDER 32 0.0083
300 ABDOMINAL TENDERNESS 41 0.0082
301 URINARY INCONTINENCE 244 0.0082
302 CATHETER SITE INFECTION 31 0.0082
303 PRODUCT COLOUR ISSUE 42 0.0082
304 PRODUCT DISPENSING ISSUE 35 0.0082
305 THINKING ABNORMAL 152 0.0081
306 BLADDER DISORDER 81 0.0081
307 SLEEP DISORDER 572 0.0081
308 UROSEPSIS 74 0.0080
309 WRIST FRACTURE 96 0.0080
310 GENERAL SYMPTOM 60 0.0080
311 SPINAL OPERATION 98 0.0079
312 SOMNAMBULISM 52 0.0079
313 CONSTIPATION 1714 0.0079
314 MEMORY IMPAIRMENT 1075 0.0078
315 DRY MOUTH 633 0.0078
316 EATING DISORDER 166 0.0078
317 SOPOR 103 0.0078
318 OROPHARYNGEAL DISCOMFORT 70 0.0077
319 DEVICE LEAKAGE 332 0.0076
320 ENERGY INCREASED 45 0.0076
321 PANIC REACTION 55 0.0076
322 APATHY 111 0.0076
323 RETCHING 160 0.0075
324 INCORRECT DOSE ADMINISTERED BY DEVICE 196 0.0075
325 MUSCLE TIGHTNESS 121 0.0075
326 CEREBRAL HAEMATOMA 25 0.0074
327 FEELING DRUNK 55 0.0074
328 INGUINAL HERNIA 45 0.0074
329 COLITIS MICROSCOPIC 35 0.0074
330 FOOT DEFORMITY 81 0.0073
331 DIPLOPIA 189 0.0073
332 MITRAL VALVE INCOMPETENCE 82 0.0072
333 REFUSAL OF TREATMENT BY PATIENT 47 0.0072
334 GENERAL PHYSICAL HEALTH DETERIORATION 822 0.0071
335 LOSS OF CONSCIOUSNESS 906 0.0071
336 CARDIAC PACEMAKER INSERTION 42 0.0070
337 INTENTIONAL DEVICE MISUSE 31 0.0070
338 ILEUS 87 0.0070
339 BLOOD PRESSURE ABNORMAL 139 0.0070
340 MUSCLE TWITCHING 161 0.0070
341 URINARY RETENTION 232 0.0069
342 HEAD DISCOMFORT 123 0.0069
343 EUPHORIC MOOD 71 0.0069
344 VITAMIN B12 DEFICIENCY 28 0.0069
345 FEELING JITTERY 131 0.0069
346 CONDITION AGGRAVATED 2063 0.0068
347 GENERAL PHYSICAL CONDITION ABNORMAL 46 0.0068
348 PARALYSIS 97 0.0068
349 MENTAL IMPAIRMENT 164 0.0068
350 TEARFULNESS 29 0.0067
351 MALABSORPTION 35 0.0067
352 ADVERSE DRUG REACTION 602 0.0067
353 ENURESIS 27 0.0067
354 LETHARGY 384 0.0067
355 PANIC ATTACK 242 0.0066
356 HYPERTONIA 38 0.0066
357 MENTAL STATUS CHANGES 184 0.0066
358 SPINAL OSTEOARTHRITIS 58 0.0066
359 DEPRESSED MOOD 348 0.0066
360 UPPER LIMB FRACTURE 131 0.0066
361 SEROTONIN SYNDROME 126 0.0066
362 APPLICATION SITE REACTION 46 0.0065
363 SPINAL COMPRESSION FRACTURE 54 0.0065
364 JOINT DISLOCATION 69 0.0065
365 COORDINATION ABNORMAL 91 0.0065
366 FEELING ABNORMAL 1555 0.0065
367 FORMICATION 45 0.0065
368 SCOLIOSIS 40 0.0065
369 INSOMNIA 1717 0.0064
370 LIMB DISCOMFORT 199 0.0064
371 EYE MOVEMENT DISORDER 44 0.0064
372 HYPERTHERMIA 49 0.0064
373 DISTURBANCE IN ATTENTION 346 0.0064
374 SYNCOPE 640 0.0064
375 FEAR 172 0.0064
376 TROPONIN INCREASED 48 0.0063
377 FEELING OF DESPAIR 29 0.0062
378 HYPOTENSION 1247 0.0062
379 CONCUSSION 48 0.0062
380 THROAT IRRITATION 277 0.0062
381 LACERATION 58 0.0062
382 DIZZINESS 3068 0.0061
383 NERVOUSNESS 321 0.0061
384 BODY HEIGHT DECREASED 65 0.0061
385 TREATMENT NONCOMPLIANCE 330 0.0060
386 CACHEXIA 31 0.0060
387 SUBDURAL HAEMATOMA 86 0.0060
388 ANXIETY 1708 0.0060
389 PSYCHIATRIC SYMPTOM 44 0.0060
390 THERAPEUTIC RESPONSE UNEXPECTED 267 0.0059
391 WEIGHT DECREASED 1657 0.0059
392 SPINAL COLUMN STENOSIS 28 0.0059
393 TRANSIENT ISCHAEMIC ATTACK 198 0.0059
394 ASTHENIA 2202 0.0059
395 DYSPHONIA 342 0.0058
396 MUSCULAR WEAKNESS 655 0.0058
397 POLYNEUROPATHY 69 0.0058
398 SARS-COV-2 TEST POSITIVE 76 0.0057
399 MUSCULOSKELETAL DISORDER 108 0.0057
400 SENSORY DISTURBANCE 91 0.0057
401 ALTERED STATE OF CONSCIOUSNESS 122 0.0056
402 ABASIA 139 0.0056
403 HYPERNATRAEMIA 28 0.0056
404 DRUG INTERACTION 887 0.0056
405 INFUSION SITE PAIN 72 0.0056
406 HYPERHIDROSIS 718 0.0056
407 DEPRESSED LEVEL OF CONSCIOUSNESS 220 0.0056
408 DRUG EFFECT DECREASED 297 0.0055
409 SPINAL FRACTURE 109 0.0054
410 PRODUCT DOSE OMISSION 355 0.0054
411 DEFAECATION URGENCY 38 0.0054
412 CARDIAC VALVE DISEASE 31 0.0054
413 BLEPHAROSPASM 34 0.0054
414 PRODUCT AVAILABILITY ISSUE 122 0.0054
415 DEHYDRATION 712 0.0053
416 MOOD ALTERED 145 0.0053
417 CHROMATURIA 120 0.0053
418 PEMPHIGOID 40 0.0053
419 SUDDEN DEATH 56 0.0053
420 HIP ARTHROPLASTY 81 0.0053
421 ILL-DEFINED DISORDER 320 0.0053
422 ORAL DISCOMFORT 73 0.0052
423 POLLAKIURIA 219 0.0052
424 SEDATION 137 0.0052
425 FEMUR FRACTURE 160 0.0052
426 APPETITE DISORDER 34 0.0051
427 DECREASED ACTIVITY 55 0.0051
428 PERIPHERAL COLDNESS 70 0.0051
429 PRESYNCOPE 122 0.0050
430 HERNIA 97 0.0050
431 IMPAIRED DRIVING ABILITY 57 0.0050
432 PERIPHERAL SWELLING 765 0.0050
433 UNDERDOSE 362 0.0050
434 ECONOMIC PROBLEM 75 0.0049
435 ANGER 167 0.0049
436 LIMB INJURY 134 0.0049
437 CYSTITIS 157 0.0049
438 ENCEPHALOPATHY 120 0.0049
439 COLD SWEAT 86 0.0049
440 WEIGHT FLUCTUATION 51 0.0049
441 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 50 0.0049
442 TONGUE DISORDER 35 0.0048
443 AFFECTIVE DISORDER 38 0.0048
444 JOINT INJURY 103 0.0048
445 MUSCLE DISORDER 39 0.0048
446 POST PROCEDURAL COMPLICATION 92 0.0048
447 BRAIN FOG 75 0.0048
448 ACUTE RESPIRATORY FAILURE 92 0.0048
449 BACK INJURY 52 0.0048
450 MENTAL DISORDER 207 0.0048
451 DEVICE DELIVERY SYSTEM ISSUE 130 0.0047
452 DEVICE RELATED INFECTION 73 0.0047
453 MUSCLE STRAIN 41 0.0047
454 CLOSTRIDIUM DIFFICILE COLITIS 50 0.0047
455 DUODENAL ULCER 33 0.0047
456 BLOOD SODIUM DECREASED 88 0.0047
457 SOCIAL AVOIDANT BEHAVIOUR 27 0.0047
458 SKIN MASS 31 0.0046
459 LOWER LIMB FRACTURE 89 0.0046
460 SECRETION DISCHARGE 58 0.0046
461 MUSCLE SPASMS 845 0.0046
462 EXPIRED PRODUCT ADMINISTERED 152 0.0046
463 ANOSMIA 66 0.0046
464 PRODUCT ADMINISTRATION ERROR 92 0.0045
465 CATARACT OPERATION 27 0.0045
466 ANURIA 39 0.0045
467 DEATH 3897 0.0045
468 RESPIRATION ABNORMAL 31 0.0045
469 PRODUCT SUBSTITUTION ISSUE 257 0.0045
470 HYPOTHERMIA 45 0.0044
471 DEPRESSION 992 0.0044
472 EXTRAPYRAMIDAL DISORDER 108 0.0043
473 ACTIVITIES OF DAILY LIVING IMPAIRED 86 0.0043
474 TOOTH EXTRACTION 54 0.0043
475 CARDIOMEGALY 53 0.0043
476 PRODUCT DOSE OMISSION ISSUE 1265 0.0043
477 WHITE BLOOD CELL COUNT INCREASED 165 0.0043
478 ATAXIA 51 0.0043
479 DEVICE DEFECTIVE 74 0.0043
480 MAJOR DEPRESSION 31 0.0042
481 BLOOD UREA INCREASED 71 0.0042
482 CORONAVIRUS INFECTION 28 0.0042
483 PRODUCT DISPENSING ERROR 92 0.0042
484 SENSORY LOSS 34 0.0042
485 INTESTINAL OBSTRUCTION 159 0.0042
486 CEREBRAL HAEMORRHAGE 151 0.0042
487 OEDEMA PERIPHERAL 514 0.0042
488 DRUG INEFFECTIVE 5527 0.0042
489 PROCEDURAL COMPLICATION 32 0.0042
490 HOSPITALISATION 640 0.0042
491 BLOOD PRESSURE INCREASED 633 0.0041
492 SCIATICA 66 0.0041
493 ATRIAL FLUTTER 33 0.0041
494 SUBARACHNOID HAEMORRHAGE 42 0.0041
495 WOUND INFECTION 45 0.0041
496 GLAUCOMA 79 0.0041
497 SURGERY 240 0.0041
498 CONTUSION 394 0.0041
499 SLEEP APNOEA SYNDROME 78 0.0041
500 DIVERTICULUM 29 0.0041
501 BLOOD CREATINE PHOSPHOKINASE INCREASED 117 0.0041
502 DRUG INTOLERANCE 390 0.0040
503 MALIGNANT MELANOMA 54 0.0040
504 NERVE COMPRESSION 37 0.0040
505 FACIAL PARALYSIS 34 0.0040
506 CATARACT 237 0.0040
507 MALAISE 1740 0.0040
508 ATRIAL FIBRILLATION 386 0.0040
509 SEPSIS 442 0.0040
510 EMOTIONAL DISORDER 122 0.0040
511 RESPIRATORY RATE INCREASED 35 0.0039
512 PHARMACEUTICAL PRODUCT COMPLAINT 102 0.0039
513 PYELONEPHRITIS 34 0.0039
514 AMNESIA 255 0.0039
515 POLYURIA 32 0.0039
516 IMPAIRED QUALITY OF LIFE 56 0.0039
517 ROTATOR CUFF SYNDROME 50 0.0039
518 DECREASED APPETITE 903 0.0039
519 MUSCLE ATROPHY 49 0.0039
520 HYPERLIPIDAEMIA 46 0.0038
521 NEPHROLITHIASIS 176 0.0038
522 PNEUMONIA 1240 0.0038
523 HEART RATE DECREASED 134 0.0038
524 FEELING COLD 106 0.0038
525 HYPOTONIA 38 0.0038
526 QUALITY OF LIFE DECREASED 51 0.0038
527 CRYING 138 0.0038
528 DENTAL CARIES 42 0.0038
529 TARDIVE DYSKINESIA 107 0.0038
530 BLOOD IRON DECREASED 45 0.0038
531 BLOOD POTASSIUM DECREASED 114 0.0038
532 PALLOR 103 0.0038
533 NASAL DISCOMFORT 30 0.0038
534 BACK DISORDER 61 0.0037
535 SEIZURE 431 0.0037
536 INABILITY TO AFFORD MEDICATION 37 0.0037
537 APNOEA 29 0.0037
538 CLOSTRIDIUM DIFFICILE INFECTION 81 0.0037
539 DISCOMFORT 225 0.0037
540 ASPHYXIA 30 0.0037
541 HEART RATE IRREGULAR 83 0.0037
542 HICCUPS 30 0.0037
543 PRODUCT PRESCRIBING ERROR 87 0.0036
544 NAUSEA 2886 0.0036
545 GRIP STRENGTH DECREASED 32 0.0036
546 SINUS BRADYCARDIA 35 0.0036
547 NEUTROPHIL COUNT INCREASED 37 0.0036
548 MIOSIS 29 0.0036
549 HYPOACUSIS 155 0.0036
550 AKATHISIA 49 0.0036
551 SPINAL DISORDER 34 0.0036
552 CARDIAC MURMUR 31 0.0036
553 PULMONARY THROMBOSIS 39 0.0036
554 KNEE ARTHROPLASTY 75 0.0036
555 HIATUS HERNIA 46 0.0035
556 INJECTION SITE NODULE 39 0.0035
557 EYELID PTOSIS 36 0.0035
558 THERAPY NON-RESPONDER 159 0.0035
559 ATELECTASIS 34 0.0035
560 LOWER GASTROINTESTINAL HAEMORRHAGE 26 0.0035
561 RHABDOMYOLYSIS 146 0.0035
562 INTERNAL HAEMORRHAGE 40 0.0035
563 SEXUAL DYSFUNCTION 41 0.0035
564 ANKLE FRACTURE 54 0.0035
565 ADVERSE REACTION 46 0.0035
566 KNEE OPERATION 34 0.0035
567 PRODUCT DISTRIBUTION ISSUE 32 0.0034
568 FRACTURE 65 0.0034
569 ACCIDENT 41 0.0034
570 MYDRIASIS 44 0.0034
571 CARPAL TUNNEL SYNDROME 48 0.0034
572 OSTEOMYELITIS 62 0.0034
573 SCRATCH 36 0.0034
574 SMALL INTESTINAL OBSTRUCTION 42 0.0034
575 RENAL CYST 27 0.0034
576 INTESTINAL PERFORATION 38 0.0034
577 TACHYPNOEA 46 0.0034
578 HAEMATOCRIT DECREASED 67 0.0034
579 IRRITABILITY 203 0.0034
580 TOOTH FRACTURE 37 0.0034
581 FEELING HOT 205 0.0033
582 RHINORRHOEA 216 0.0033
583 PRODUCTIVE COUGH 159 0.0033
584 SENSATION OF FOREIGN BODY 28 0.0033
585 ELECTROCARDIOGRAM ABNORMAL 26 0.0033
586 FATIGUE 2558 0.0033
587 COMA 155 0.0033
588 INTERVERTEBRAL DISC PROTRUSION 71 0.0032
589 BLOOD MAGNESIUM DECREASED 28 0.0032
590 RESPIRATORY DISORDER 97 0.0032
591 LIGAMENT SPRAIN 32 0.0032
592 HYPERTENSIVE CRISIS 36 0.0032
593 SUICIDAL IDEATION 296 0.0032
594 IMPAIRED GASTRIC EMPTYING 44 0.0032
595 ABDOMINAL DISCOMFORT 541 0.0032
596 COVID-19 PNEUMONIA 38 0.0032
597 HYPONATRAEMIA 181 0.0032
598 NEURALGIA 78 0.0032
599 HAEMATOMA 83 0.0032
600 CEREBROVASCULAR ACCIDENT 542 0.0032
601 INTERNATIONAL NORMALISED RATIO INCREASED 91 0.0032
602 NECK PAIN 178 0.0032
603 PRODUCT PRESCRIBING ISSUE 69 0.0032
604 KIDNEY INFECTION 62 0.0032
605 VITAMIN D DECREASED 27 0.0032
606 APHONIA 44 0.0031
607 FAECES DISCOLOURED 68 0.0031
608 BIPOLAR DISORDER 34 0.0031
609 ILLNESS 321 0.0031
610 BLOOD URINE PRESENT 59 0.0031
611 THROAT TIGHTNESS 84 0.0031
612 MACULAR DEGENERATION 37 0.0031
613 DYSURIA 114 0.0031
614 BRADYCARDIA 164 0.0031
615 INTENTIONAL DOSE OMISSION 88 0.0031
616 ACUTE MYOCARDIAL INFARCTION 91 0.0031
617 HEMIPARESIS 52 0.0031
618 JOINT RANGE OF MOTION DECREASED 41 0.0031
619 VERTIGO 186 0.0030
620 PROSTATIC SPECIFIC ANTIGEN INCREASED 42 0.0030
621 WOUND 85 0.0030
622 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 548 0.0030
623 COVID-19 533 0.0030
624 RESPIRATORY FAILURE 221 0.0030
625 ANOREXIA 39 0.0030
626 LOCALISED INFECTION 73 0.0030
627 HYPERTENSION 638 0.0030
628 HAEMORRHAGE INTRACRANIAL 45 0.0030
629 TASTE DISORDER 61 0.0030
630 VISUAL IMPAIRMENT 372 0.0030
631 PRODUCT DOSE OMISSION IN ERROR 85 0.0030
632 WITHDRAWAL SYNDROME 126 0.0030
633 BRAIN INJURY 30 0.0030
634 MYOCARDIAL ISCHAEMIA 34 0.0030
635 MOOD SWINGS 95 0.0030
636 ABDOMINAL DISTENSION 309 0.0030
637 ROAD TRAFFIC ACCIDENT 123 0.0029
638 CELLULITIS 148 0.0029
639 INTERVERTEBRAL DISC DEGENERATION 27 0.0029
640 APPLICATION SITE PRURITUS 66 0.0029
641 DYSPNOEA 1645 0.0029
642 PNEUMOTHORAX 46 0.0029
643 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 586 0.0029
644 OXYGEN SATURATION DECREASED 162 0.0029
645 OSTEOARTHRITIS 122 0.0029
646 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 150 0.0029
647 VITAMIN D DEFICIENCY 28 0.0029
648 SQUAMOUS CELL CARCINOMA 27 0.0029
649 AGEUSIA 71 0.0028
650 MUSCULOSKELETAL CHEST PAIN 44 0.0028
651 CARDIAC FAILURE CONGESTIVE 228 0.0028
652 PRODUCT USE ISSUE 532 0.0028
653 SEASONAL ALLERGY 40 0.0028
654 LACRIMATION INCREASED 85 0.0028
655 DEVICE USE ERROR 97 0.0028
656 GASTRITIS 73 0.0028
657 BLOOD POTASSIUM INCREASED 45 0.0028
658 SKIN INFECTION 31 0.0028
659 PHARYNGEAL SWELLING 27 0.0028
660 NODULE 36 0.0028
661 PULMONARY MASS 41 0.0027
662 DISEASE PROGRESSION 325 0.0027
663 VITREOUS FLOATERS 27 0.0027
664 PAIN IN EXTREMITY 809 0.0027
665 FOOT FRACTURE 52 0.0027
666 GASTRIC DISORDER 94 0.0027
667 PRODUCT PACKAGING ISSUE 26 0.0027
668 FLUID RETENTION 139 0.0027
669 GASTROINTESTINAL PAIN 30 0.0027
670 PULMONARY OEDEMA 122 0.0027
671 CHOLELITHIASIS 89 0.0027
672 ACCIDENTAL UNDERDOSE 39 0.0027
673 BACK PAIN 629 0.0027
674 AFFECT LABILITY 26 0.0027
675 HYPOXIA 95 0.0027
676 THERAPEUTIC RESPONSE DECREASED 163 0.0027
677 MEDICATION ERROR 149 0.0027
678 GASTROINTESTINAL DISORDER 240 0.0027
679 DYSPEPSIA 263 0.0027
680 INCREASED APPETITE 51 0.0027
681 JOINT STIFFNESS 70 0.0027
682 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
683 HYPOMAGNESAEMIA 37 0.0027
684 ARTERIOSCLEROSIS 25 0.0027
685 PULMONARY CONGESTION 35 0.0027
686 FLATULENCE 150 0.0026
687 RESPIRATORY DISTRESS 73 0.0026
688 PULMONARY HYPERTENSION 55 0.0026
689 ULCER 42 0.0026
690 HYPOAESTHESIA 394 0.0026
691 GASTRIC ULCER 50 0.0026
692 DERMATITIS CONTACT 30 0.0026
693 VOMITING 1234 0.0026
694 CHOLECYSTITIS 31 0.0026
695 SKIN CANCER 56 0.0026
696 VISION BLURRED 357 0.0026
697 VENTRICULAR EXTRASYSTOLES 27 0.0026
698 LUNG DISORDER 127 0.0026
699 PRODUCT TASTE ABNORMAL 35 0.0026
700 STAPHYLOCOCCAL INFECTION 85 0.0026
701 STATUS EPILEPTICUS 29 0.0026
702 BLOOD PRESSURE SYSTOLIC INCREASED 50 0.0026
703 THERAPY INTERRUPTED 183 0.0026
704 MUSCULOSKELETAL DISCOMFORT 44 0.0026
705 EYE DISORDER 84 0.0026
706 INCORRECT DOSE ADMINISTERED 583 0.0026
707 GASTROINTESTINAL HAEMORRHAGE 213 0.0025
708 ORAL PAIN 57 0.0025
709 ABDOMINAL PAIN 592 0.0025
710 CARDIAC ARREST 210 0.0025
711 CYANOSIS 40 0.0025
712 EXTRA DOSE ADMINISTERED 103 0.0025
713 LEUKOCYTOSIS 46 0.0025
714 CIRCULATORY COLLAPSE 43 0.0025
715 NERVE INJURY 28 0.0025
716 PLEURAL EFFUSION 153 0.0025
717 BLOOD ALKALINE PHOSPHATASE INCREASED 62 0.0025
718 RESPIRATORY TRACT INFECTION 65 0.0025
719 SUICIDE ATTEMPT 151 0.0025
720 WRONG TECHNIQUE IN DRUG USAGE PROCESS 90 0.0025
721 CARDIAC FAILURE 197 0.0025
722 APPLICATION SITE ERYTHEMA 64 0.0024
723 HAEMATURIA 83 0.0024
724 INFECTION 350 0.0024
725 SKIN DISCOLOURATION 111 0.0024
726 CHEST DISCOMFORT 245 0.0024
727 TOOTH DISORDER 53 0.0024
728 GASTROENTERITIS VIRAL 43 0.0024
729 CHEST PAIN 440 0.0024
730 HEART RATE INCREASED 235 0.0024
731 BRONCHITIS 175 0.0024
732 MELAENA 52 0.0024
733 SKIN ULCER 61 0.0024
734 TENDON RUPTURE 29 0.0023
735 COLON CANCER 35 0.0023
736 PULMONARY EMBOLISM 223 0.0023
737 CORONARY ARTERY OCCLUSION 32 0.0023
738 RECTAL HAEMORRHAGE 100 0.0023
739 EPILEPSY 71 0.0023
740 PROCEDURAL PAIN 64 0.0023
741 MUSCLE SPASTICITY 28 0.0023
742 CHOLECYSTECTOMY 26 0.0023
743 DIVERTICULITIS 63 0.0023
744 INTENTIONAL PRODUCT MISUSE 199 0.0023
745 CARDIAC DISORDER 212 0.0023
746 RESPIRATORY TRACT CONGESTION 36 0.0023
747 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 124 0.0023
748 ARRHYTHMIA 107 0.0023
749 HAEMOGLOBIN DECREASED 232 0.0023
750 BODY TEMPERATURE INCREASED 46 0.0023
751 NEUROPATHY PERIPHERAL 214 0.0022
752 CORONARY ARTERY DISEASE 68 0.0022
753 DRUG LEVEL INCREASED 37 0.0022
754 ABDOMINAL PAIN UPPER 459 0.0022
755 SNEEZING 50 0.0022
756 HOT FLUSH 168 0.0022
757 EOSINOPHILIA 39 0.0022
758 ELECTROCARDIOGRAM QT PROLONGED 80 0.0022
759 RENAL FAILURE 293 0.0022
760 TOOTH INFECTION 29 0.0022
761 BACTERIAL INFECTION 41 0.0022
762 DYSGEUSIA 163 0.0022
763 GASTROOESOPHAGEAL REFLUX DISEASE 176 0.0022
764 INTENTIONAL PRODUCT USE ISSUE 191 0.0022
765 SHOCK 50 0.0022
766 CARDIOMYOPATHY 32 0.0022
767 HAEMORRHOIDS 42 0.0022
768 ELECTROLYTE IMBALANCE 25 0.0021
769 HYPOGLYCAEMIA 104 0.0021
770 BURSITIS 26 0.0021
771 PARAESTHESIA 337 0.0021
772 RED BLOOD CELL COUNT DECREASED 61 0.0021
773 CEREBRAL INFARCTION 52 0.0021
774 PAIN IN JAW 60 0.0021
775 PALPITATIONS 247 0.0021
776 RENAL FAILURE ACUTE 89 0.0021
777 DRUG DISPENSING ERROR 32 0.0021
778 BURNING SENSATION 146 0.0021
779 THYROID DISORDER 32 0.0021
780 PLATELET COUNT INCREASED 27 0.0021
781 ABSCESS 33 0.0021
782 MUSCULOSKELETAL PAIN 108 0.0021
783 PAIN 1266 0.0021
784 VENTRICULAR TACHYCARDIA 34 0.0021
785 COLITIS 78 0.0021
786 HYPOAESTHESIA ORAL 31 0.0021
787 JOINT SWELLING 248 0.0021
788 DRUG ADMINISTRATION ERROR 63 0.0021
789 NIGHT SWEATS 66 0.0020
790 NASAL CONGESTION 120 0.0020
791 BLOOD CREATININE INCREASED 133 0.0020
792 WEIGHT INCREASED 453 0.0020
793 ARTHRITIS 159 0.0020
794 OVERDOSE 435 0.0020
795 THIRST 36 0.0020
796 THROMBOSIS 161 0.0020
797 FREQUENT BOWEL MOVEMENTS 54 0.0020
798 INJURY 140 0.0020
799 NERVOUS SYSTEM DISORDER 62 0.0020
800 SWOLLEN TONGUE 62 0.0020
801 LIP SWELLING 66 0.0020
802 INTENTIONAL SELF-INJURY 40 0.0020
803 UPPER RESPIRATORY TRACT INFECTION 91 0.0020
804 ACCIDENTAL OVERDOSE 72 0.0020
805 RESPIRATORY ARREST 54 0.0020
806 IMPAIRED HEALING 64 0.0019
807 CONVULSION 111 0.0019
808 ABDOMINAL PAIN LOWER 49 0.0019
809 INFLUENZA 216 0.0019
810 MYOCARDIAL INFARCTION 337 0.0019
811 OEDEMA 104 0.0019
812 BLINDNESS UNILATERAL 27 0.0019
813 DRUG TOXICITY 26 0.0019
814 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 135 0.0019
815 TINNITUS 87 0.0019
816 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
817 FUNGAL INFECTION 63 0.0019
818 HEADACHE 1183 0.0019
819 OSTEOPOROSIS 77 0.0019
820 COAGULOPATHY 31 0.0019
821 THERAPY PARTIAL RESPONDER 29 0.0019
822 MYALGIA 316 0.0019
823 HAEMATEMESIS 47 0.0019
824 GASTROENTERITIS 27 0.0018
825 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
826 ISCHAEMIC STROKE 33 0.0018
827 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
828 ERECTILE DYSFUNCTION 47 0.0018
829 HYPERKALAEMIA 64 0.0018
830 HYPOKALAEMIA 84 0.0018
831 ERUCTATION 35 0.0018
832 LOWER RESPIRATORY TRACT INFECTION 82 0.0018
833 MULTIPLE ORGAN DYSFUNCTION SYNDROME 51 0.0018
834 ANAEMIA 338 0.0018
835 OROPHARYNGEAL PAIN 163 0.0018
836 BLOOD CHOLESTEROL INCREASED 82 0.0018
837 BONE DISORDER 32 0.0018
838 SKIN HAEMORRHAGE 26 0.0018
839 CARDIO-RESPIRATORY ARREST 73 0.0017
840 VIRAL INFECTION 58 0.0017
841 GALLBLADDER DISORDER 31 0.0017
842 C-REACTIVE PROTEIN INCREASED 63 0.0017
843 DEAFNESS 45 0.0017
844 PULMONARY FIBROSIS 33 0.0017
845 DRUG PRESCRIBING ERROR 33 0.0017
846 WHEEZING 101 0.0017
847 ACUTE KIDNEY INJURY 259 0.0017
848 PERITONITIS 35 0.0017
849 TACHYCARDIA 150 0.0017
850 PERICARDIAL EFFUSION 39 0.0017
851 CHILLS 197 0.0017
852 SWELLING 157 0.0017
853 GOUT 30 0.0017
854 DISABILITY 33 0.0017
855 BASAL CELL CARCINOMA 26 0.0017
856 EAR INFECTION 44 0.0017
857 RENAL DISORDER 77 0.0017
858 INTENTIONAL OVERDOSE 106 0.0017
859 DEEP VEIN THROMBOSIS 107 0.0016
860 PYREXIA 569 0.0016
861 EMOTIONAL DISTRESS 199 0.0016
862 LYMPHOCYTE COUNT DECREASED 29 0.0016
863 HYPOCALCAEMIA 31 0.0016
864 JAUNDICE 44 0.0016
865 DIARRHOEA 1053 0.0016
866 ARTHROPATHY 90 0.0016
867 SINUS DISORDER 32 0.0016
868 DRUG DOSE OMISSION 267 0.0016
869 EPISTAXIS 120 0.0016
870 SKIN LESION 44 0.0016
871 TOOTHACHE 29 0.0016
872 CANDIDA INFECTION 27 0.0016
873 HYPOTHYROIDISM 51 0.0016
874 BLISTER 89 0.0016
875 BLOOD GLUCOSE DECREASED 76 0.0016
876 ANGINA PECTORIS 45 0.0016
877 DYSPNOEA EXERTIONAL 59 0.0016
878 SKIN DISORDER 52 0.0016
879 ARTHRALGIA 647 0.0016
880 FLUSHING 158 0.0016
881 HERPES ZOSTER 89 0.0015
882 DRY EYE 77 0.0015
883 SEPTIC SHOCK 67 0.0015
884 CARDIOVASCULAR DISORDER 39 0.0015
885 RASH PRURITIC 83 0.0015
886 INCORRECT PRODUCT ADMINISTRATION DURATION 33 0.0015
887 HAEMOPTYSIS 42 0.0015
888 PHOTOPHOBIA 28 0.0015
889 LACTIC ACIDOSIS 48 0.0015
890 DERMATITIS 31 0.0015
891 PANCREATITIS 78 0.0015
892 SWELLING FACE 95 0.0015
893 DRUG WITHDRAWAL SYNDROME 128 0.0015
894 ASPARTATE AMINOTRANSFERASE INCREASED 77 0.0014
895 TOOTH LOSS 30 0.0014
896 NASOPHARYNGITIS 266 0.0014
897 EAR PAIN 28 0.0014
898 DIABETES MELLITUS 109 0.0014
899 DRUG ABUSE 119 0.0014
900 INFLAMMATION 73 0.0014
901 CHOLESTASIS 27 0.0014
902 HYPERGLYCAEMIA 51 0.0014
903 PRODUCT ADHESION ISSUE 50 0.0014
904 HEPATIC STEATOSIS 26 0.0014
905 PRODUCT USE IN UNAPPROVED INDICATION 345 0.0014
906 NEOPLASM MALIGNANT 91 0.0014
907 HAEMATOCHEZIA 75 0.0014
908 ERYTHEMA 271 0.0013
909 HAEMORRHAGE 136 0.0013
910 RASH ERYTHEMATOUS 62 0.0013
911 SKIN IRRITATION 59 0.0013
912 OFF LABEL USE 1112 0.0013
913 HYPERSENSITIVITY 235 0.0013
914 GLOSSODYNIA 28 0.0012
915 PANCREATITIS ACUTE 28 0.0012
916 RASH MACULAR 43 0.0012
917 BLINDNESS 50 0.0012
918 RENAL IMPAIRMENT 103 0.0012
919 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
920 VISUAL ACUITY REDUCED 40 0.0012
921 TYPE 2 DIABETES MELLITUS 40 0.0012
922 RASH 497 0.0011
923 PRODUCT STORAGE ERROR 99 0.0011
924 HEPATIC FAILURE 34 0.0011
925 METABOLIC ACIDOSIS 36 0.0011
926 THROMBOCYTOPENIA 125 0.0011
927 PNEUMONITIS 30 0.0011
928 BONE PAIN 64 0.0011
929 TOXICITY TO VARIOUS AGENTS 184 0.0011
930 LABORATORY TEST ABNORMAL 32 0.0011
931 INJECTION SITE MASS 40 0.0011
932 DEVICE MALFUNCTION 76 0.0011
933 INJECTION SITE BRUISING 86 0.0011
934 ALANINE AMINOTRANSFERASE INCREASED 66 0.0011
935 INCORRECT DRUG ADMINISTRATION DURATION 30 0.0011
936 PRODUCT QUALITY ISSUE 144 0.0011
937 LEUKOPENIA 53 0.0011
938 CHRONIC KIDNEY DISEASE 80 0.0011
939 INJECTION SITE PRURITUS 70 0.0010
940 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35 0.0010
941 LIVER FUNCTION TEST ABNORMAL 30 0.0010
942 COMPLETED SUICIDE 85 0.0010
943 SINUSITIS 104 0.0010
944 EYE IRRITATION 58 0.0010
945 RASH GENERALISED 26 0.0010
946 ECZEMA 52 0.0010
947 OCULAR HYPERAEMIA 47 0.0010
948 ANHEDONIA 26 0.0010
949 STOMATITIS 60 0.0010
950 BLOOD BILIRUBIN INCREASED 26 0.0010
951 EYE PAIN 54 0.0010
952 PRURITUS 365 0.0009
953 LIVER DISORDER 42 0.0009
954 ASTHMA 106 0.0009
955 NEUTROPHIL COUNT DECREASED 38 0.0009
956 DEVICE EXPULSION 60 0.0009
957 WHITE BLOOD CELL COUNT DECREASED 100 0.0009
958 INCORRECT ROUTE OF DRUG ADMINISTRATION 32 0.0009
959 PROSTATE CANCER 72 0.0009
960 EYE PRURITUS 30 0.0009
961 INJECTION SITE ERYTHEMA 109 0.0009
962 LUNG NEOPLASM MALIGNANT 36 0.0009
963 INFLUENZA LIKE ILLNESS 71 0.0009
964 BLOOD GLUCOSE INCREASED 156 0.0008
965 LYMPHADENOPATHY 29 0.0008
966 NO ADVERSE EVENT 147 0.0008
967 MIGRAINE 75 0.0008
968 ALOPECIA 153 0.0008
969 PLATELET COUNT DECREASED 83 0.0008
970 PLASMA CELL MYELOMA 30 0.0008
971 SKIN EXFOLIATION 63 0.0007
972 DISEASE RECURRENCE 35 0.0007
973 HEPATIC ENZYME INCREASED 50 0.0007
974 EYE SWELLING 27 0.0007
975 URTICARIA 112 0.0007
976 NEUTROPENIA 90 0.0007
977 DRY SKIN 84 0.0006
978 DEPENDENCE 32 0.0006
979 TREATMENT FAILURE 48 0.0006
980 PANCYTOPENIA 32 0.0006
981 INJECTION SITE HAEMORRHAGE 45 0.0006
982 INTERSTITIAL LUNG DISEASE 27 0.0006
983 INJECTION SITE SWELLING 42 0.0005
984 MULTIPLE SCLEROSIS RELAPSE 37 0.0005
985 INJECTION SITE REACTION 37 0.0005
986 DRUG DEPENDENCE 81 0.0005
987 BLADDER CANCER 26 0.0004
988 RHEUMATOID ARTHRITIS 47 0.0004
989 PSORIASIS 54 0.0004
990 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
991 ACCIDENTAL EXPOSURE TO PRODUCT 40 0.0004
992 INJECTION SITE PAIN 113 0.0004
993 BREAST CANCER 34 0.0004
994 SKIN BURNING SENSATION 26 0.0004